• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Direxion Daily S&P Biotech Bear 3X ETF (NY:LABD)

    13.54 -0.30 (-2.17%)
    Official Closing Price Updated: 8:00 PM EDT, May 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,497,308
    Open 13.74
    Bid (Size) 13.49 (1,400)
    Ask (Size) 13.70 (1,000)
    Prev. Close 13.84
    Today's Range 13.19 - 13.99
    52wk Range 12.46 - 101.00
    Shares Outstanding 129,160
    Dividend Yield 2.51%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗
    Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment. 
    Via Benzinga
    News headline image
    5 Inverse ETFs That Gained More Than 20% in April ↗
    The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market’s worst month of 2024. 
    Via Talk Markets
    Topics ETFs

    Performance

    YTD
    -36.4%
    -36.4%
    1 Month
    -11.3%
    -11.3%
    3 Month
    -26.9%
    -26.9%
    6 Month
    -56.4%
    -56.4%
    1 Year
    -85.3%
    -85.3%

    More News

    Read More
    News headline image
    5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3 ↗
    Via Talk Markets
    Topics ETFs
    News headline image
    5 Inverse ETFs That Gained In Double Digits In August ↗
    Via Talk Markets
    Topics ETFs
    News headline image
    Inverse ETFs Soar as Market Turns Sour ↗
    Via Talk Markets
    News headline image
    Want Diversified Upside in Biotechnology? Check out LABU
    Via MarketBeat
    Topics ETFs Stocks
    News headline image
    5 Best Inverse-Leveraged ETFs Of February ↗
    Via Talk Markets
    News headline image
    Stocks See Worst Day in 2 Years: Inverse ETFs Shine ↗
    Via Talk Markets
    News headline image
    5 Inverse ETFs Enjoying A Rally This Year ↗
    Via Talk Markets
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
    Via InvestorPlace
    News headline image
    5 Leveraged/Inverse ETFs Up More Than 15% in November ↗
    Via Talk Markets
    News headline image
    7 Inverse ETFs Riding High on Nasdaq Sell-Off ↗
    Via Talk Markets

    Frequently Asked Questions

    Is Direxion Daily S&P Biotech Bear 3X ETF publicly traded?
    Yes, Direxion Daily S&P Biotech Bear 3X ETF is publicly traded.
    What exchange does Direxion Daily S&P Biotech Bear 3X ETF trade on?
    Direxion Daily S&P Biotech Bear 3X ETF trades on the New York Stock Exchange
    What is the ticker symbol for Direxion Daily S&P Biotech Bear 3X ETF?
    The ticker symbol for Direxion Daily S&P Biotech Bear 3X ETF is LABD on the New York Stock Exchange
    What is the current price of Direxion Daily S&P Biotech Bear 3X ETF?
    The current price of Direxion Daily S&P Biotech Bear 3X ETF is 13.54
    When was Direxion Daily S&P Biotech Bear 3X ETF last traded?
    The last trade of Direxion Daily S&P Biotech Bear 3X ETF was at 05/08/26 08:00 PM ET
    What is the market capitalization of Direxion Daily S&P Biotech Bear 3X ETF?
    The market capitalization of Direxion Daily S&P Biotech Bear 3X ETF is 1.75M
    How many shares of Direxion Daily S&P Biotech Bear 3X ETF are outstanding?
    Direxion Daily S&P Biotech Bear 3X ETF has 2M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.